Suja Life, Inc. entered into an Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent, on August 20, 2026. This refinancing reduces the company's borrowing spread by lowering the applicable interest rate to Term SOFR plus 1.75%, 2.00%, or 2.25% per annum, based on its consolidated net leverage ratio. The transaction does not involve additional debt but aims to lower the cost of capital and improve available cash flow. As a result, Suja Life expects its total interest expense for 2026 to decrease to $18.0 million. Suja Life operates in the consumer staples industry as a manufacturer of organic cold-pressed juices, wellness shots, and better-for-you sodas.

Suja Life, Inc. reported second quarter fiscal 2026 financial results for the period ended June 29, 2026. Net sales increased 11.6% year-over-year to $83.9 million from $75.2 million, driven by volume growth and new product distribution. Gross profit margin was 46.7%, down from 47.4% in the prior year period due to unfavorable inventory absorption timing. The company reported a net loss of $(27.8) million, compared to a $(5.7) million loss previously, primarily due to $25.1 million in one-time IPO-related transaction costs and a $2.3 million loss on debt extinguishment. Adjusted EBITDA rose 50.0% to $14.6 million from $9.8 million. The company updated its full-year fiscal 2026 outlook, expecting net sales of $360 million to $369 million and Adjusted EBITDA of $70 million to $72 million. Suja Life operates in the natural healthy beverage industry, producing organic cold-pressed juices, wellness shots, and sodas.

On June 9, 2026, Suja Life, Inc. issued a press release announcing its financial results for the fiscal quarter ended March 30, 2026. The company operates in the beverage industry, producing and selling organic juices and smoothies.